Latest / Healthcare Scandal Investigations
The Drug That Turned Champions Into Cancer Labs
The Drug That Turned Champions Into Cancer Labs
A drug abandoned by its maker for causing cancer in rodents reappeared years later as a performance miracle for athletes - and by 2011 it was selling on the black market for $1,000 per 10 grams. How did a compound with no approved human dose, hidden toxicity data, and links to multi-organ cancer end up in the bloodstream of champions across continents?
In this episode, we trace the compound's journey from GlaxoSmithKline and Ligand's lab work in 1992 through clinical trials and quiet abandonment in 2007, to Salk Institute research that revealed…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.